P3 HEALTH PARTNERS INC PIII
ASignal's systematic analysis rates PIII as Bearish.
Reflects the latest available analysis · analyzed Oct 31, 2026
The case on PIII
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Price near lower Bollinger Band suggesting potential mean reversion
- Positive MACD histogram expansion indicating weakening bearish momentum
- Revenue growth of 8.6% year-over-year shows moderate top-line momentum
- EV/Revenue of 0.24x indicates low valuation relative to sales
- Negative free cash flow of $-124.25M raises sustainability concerns
- Negative return on equity (-192.58%) and negative price-to-book ratio (-0.17x) signal severe financial distress
- Operating cash flow deeply negative at $-130.52M
- Debt-to-equity ratio of 0.95x near high end of acceptable range
- Current ratio of 0.46x indicates near-term liquidity risk
- No news coverage or Reddit mentions, suggesting lack of market interest or information scarcity
See the full verdict on PIII
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes PIII
Most investors never get a second opinion, let alone several. ASignal runs PIII past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.